About RyMed

Headquartered in Franklin, Tennessee, RyMed Technologies, Inc. specializes in the development and marketing of innovative safety products in the field of intravenous catheter care and maintenance management. RyMed manufactures and distributes the InVision-Plus® with Neutral Advantage™ Technology. RyMed's Neutral Advantage™ Technology is the foundation of all InVision-Plus® products. It consists of a 10-Point Standard, ten system features designed to work in conjunction with one another to maximize intraluminal fluid pathway protection and prevent catheter-related bloodstream infections (CR-BSIs). Only the InVision-Plus® with Neutral Advantage™ Technology possesses all ten and it takes the combination of all ten features to deliver what no other competitive product can.

RyMed's products are designed to reduce the two most critical vascular access catheter issues of Catheter-related Bloodstream Infections (CR-BSI) and Intraluminal Thrombotic Catheter Occlusions. RyMed is headed by its founder, President, CEO and Chairman Dana Wm. Ryan, who is a pioneer in "safety-oriented" medical product design, and creator of the InVision-Plus® technologies.

MISSION STATEMENT

RyMed is committed to improving patient outcomes aimed at intraluminal catheter-related bloodstream infection prevention and intraluminal thrombotic catheter occlusion reduction by providing innovative product solutions possessing bona fide fail-safe engineering design technologies.

RyMed's revolutionary products empower healthcare providers to successfully apply proven infection control, catheter care and maintenance practices which support the national goal to deliver healthcare that is safe, cost-effective, and easily adopted.